Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/22921
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Peverelle, Matthew R | - |
dc.contributor.author | Asadi, Khashayar | - |
dc.contributor.author | De Cruz, Peter P | - |
dc.date | 2020-03-31 | - |
dc.date.accessioned | 2020-04-14T04:00:53Z | - |
dc.date.available | 2020-04-14T04:00:53Z | - |
dc.date.issued | 2020-10-05 | - |
dc.identifier.citation | Journal of Crohn's & Colitis 2020; 14(10): 1498-1499 | en_US |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/22921 | - |
dc.language.iso | eng | - |
dc.subject | Crohn’s disease | en_US |
dc.subject | Liver transplantation | en_US |
dc.subject | Ustekinumab | en_US |
dc.title | Ustekinumab is a safe and effective biologic agent for Crohn's disease in a Liver Transplant patient. | en_US |
dc.type | Journal Article | en_US |
dc.identifier.journaltitle | Journal of Crohn's & Colitis | en_US |
dc.identifier.affiliation | Anatomical Pathology | en_US |
dc.identifier.affiliation | Gastroenterology and Hepatology | en_US |
dc.identifier.affiliation | Medicine (University of Melbourne) | en_US |
dc.identifier.doi | 10.1093/ecco-jcc/jjaa062 | en_US |
dc.type.content | Text | en_US |
dc.identifier.orcid | 0000-0003-0136-6699 | en_US |
dc.identifier.orcid | 0000-0002-3399-7236 | en_US |
dc.identifier.pubmedid | 32232397 | - |
dc.type.austin | Journal Article | - |
local.name.researcher | Asadi, Khashayar | |
item.cerifentitytype | Publications | - |
item.grantfulltext | none | - |
item.languageiso639-1 | en | - |
item.fulltext | No Fulltext | - |
item.openairetype | Journal Article | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
crisitem.author.dept | Victorian Liver Transplant Unit | - |
crisitem.author.dept | Pathology | - |
crisitem.author.dept | Gastroenterology and Hepatology | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.